Connect with us

Technology

Implicity’s EVIDENCE-RM Study Demonstrates Marked Improvement in ICD Patient Outcomes

Published

on

Comprehensive analysis of real-world data shows significant clinical and medico-economic advantages of Implicity’s universal, alert-based remote monitoring platform

CAMBRIDGE, Mass., April 24, 2025 /PRNewswire/ — IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today unveiled new findings from its EVIDENCE-RM study¹. Leveraging extensive data from the French National Health Data System (SNDS), the study demonstrated clear clinical and medico-economic benefits associated with Implicity’s universal monitoring system (UMS) compared to conventional, manufacturer-specific systems, including Abbott, Biotronik, Boston Scientific, and Medtronic.

The study, recently published in Heart Rhythm, analyzed clinical outcomes and costs for over 69,000 patients with implantable cardioverter-defibrillators (ICDs) and defibrillators with cardiac resynchronization therapy (CRT-Ds). Patients remotely monitored using Implicity’s platform showed increased survival rates and a reduction in both the number and duration of all-cause and heart failure-related hospitalizations, resulting in substantial healthcare cost reductions. Key findings attributed to Implicity’s IM009² platform include:

26% reduction in mortality (HR, 0.74; 95% CI, 0.73–0.77; P=.001)4% decrease in HF hospitalizations, total corrected healthcare costs, and mean duration of hospitalization17.8% decrease in hospital-related costs, primarily driven by decreased costs in cardiovascular disease careIncremental Cost-Effectiveness Ratio (ICER) of approximately –$112 USD (-103€) per Day Alive and Out of Hospital (DAOH) based on the French Healthcare System

“Managing patients with ICDs and CRTs presents considerable challenges, since they are at high risk of hospitalization due to arrhythmias and heart failure,” said Dr. Niraj Varma, Professor of Medicine and Director, Cardiac Pacing & Tachyarrhythmia Devices at the Cleveland Clinic. “The EVIDENCE-RM study clearly demonstrates that a universal monitoring solution operating alert-based remote monitoring can significantly reduce these risks, improving patient outcomes and substantially lowering healthcare costs. This is an important advancement in our ability to proactively manage patients with ICDs and CRTs.”

“These findings mark a pivotal moment in remote cardiac care and prove Implicity’s effectiveness with unparalleled clinical results,” stated Implicity CEO Dr. Arnaud Rosier. “A 26% reduction in mortality and better use of healthcare resources highlight the impact of universal remote monitoring, driven by AI, over fragmented manufacturer-specific systems. Implicity is committed to driving innovation so that every cardiac patient receives proactive, efficient care.”

For more information about Implicity and the EVIDENCE-RM study, please visit www.implicity.com.

About Implicity
Implicity is a digital MedTech software company dedicated to providing the best remote care to patients with cardiac implantable electronic devices and heart failure. Co-founded by cardiac electrophysiologist Arnaud Rosier, MD, PhD, the platform aggregates, normalizes, and standardizes data from any implantable cardiac device across all manufacturers, improving care for patients with cardiac implants and heart failure.

Implicity’s platform provides critical health information augmented by FDA-cleared AI³ algorithms, enabling healthcare providers to make more informed decisions for better patient outcomes. With access to the Health Data Hub, one of the world’s largest databases of heart disease patients, Implicity is able to develop its AI solutions based on more robust data. The company is protecting more than 100,000 patients in over 200 medical facilities across the US and Europe. To learn more, visit www.implicity.com

Health Data Hub is a health data platform established by the French government to combine existing health patient databases and facilitate their usage for research and development purposes

References

N. Varma et al., “Impact of a universal monitoring system (‘third party’) on outcomes of ICD patients: A nationwide study,” Heart Rhythm, 2024.IM009: 2021. Manufacturer: Implicity. IM009 is a software as a medical device (SaMD) intended to be used as an adjunct of a remote monitoring platform to follow-up target population patients. IM009 is compatible with devices with remote monitoring feature such as cardiac implantable electronic devices and connected weight scales. The three main intents of IM009 are to (1) label observations generated by medical devices according to predefined categories, (2) create clinically relevant observations for worsening atrial fibrillation and/or rapid weight gain in the context of heart failure, based on data recorded by the device and (3) label Atrial Fibrillation burden observations generated by cardiac implantable electronic device (CIED) as to be hidden or relevant for health care provider based on patient’s anticoagulation status. Hence, IM009 is designed to reduce the workload burden of healthcare providers/professionals in charge of reviewing the observations received from the patients’ devices. IM009 is not intended for use in life supporting or sustaining systems or Alarm devices and as a solely means of diagnosis. It is offered to healthcare providers/professionals on an advisory basis only in conjunction with the physician’s knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information. Class I, according to Medical Device Directive 93/42/EEC. See the instructions for use for more information. Covered under the conditions defined in Article L. 162-52 of the French Social Security Code.IM007: 2021. ILR ECG ANALYZER created by Implicity is intended to be used by qualified healthcare professionals for the assessment of arrhythmias in Insertable Cardiac Monitor (ICM) ECG data. ILR ECG ANALYZER supports downloading and analyzing data recorded in compatible formats from ICMs. This version of the ILR ECG ANALYZER only supports ECG data from Medtronic ICMs. ILR ECG ANALYZER is intended to be electronically interfaced with other computer systems (remote monitoring platforms) that supply the ECG data to ILR ECG ANALYZER and receive the output of ILR ECG ANALYZER (analysis) for viewing by healthcare professionals. ILR ECG ANALYZER provides ECG signal processing and analysis, to detect asystole, bradycardia, atrial tachycardia or atrial fibrillation, ventricular tachycardia, normal rhythm and artifacts. ILR ECG ANALYZER is not for use in life supporting or sustaining systems or ECG monitor and Alarm devices. ILR ECG ANALYZER interpretation results are not intended to be the sole means of diagnosis. It is offered to physicians and clinicians on an advisory basis only in conjunction with the physician’s knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information. ILR ECG ANALYZER is interfaced with the compatible remote monitoring platform from which it receives compatible ICM data file input (Medtronic LNQ11 Medtronic REVEAL XT 9529 Medtronic REVEAL DX 9528) and to which it transmits the output. Read carefully all instructions before use. Results: sensitivity: 98.64 % (509/516), false positive rate: 24.03 % (68/283). FDA cleared Class II medical device and CE marked Class I medical device (under medical device directive 93/42).
SignalHF FDA cleared Class II medical device and CE marked Class IIa (under MDR) medical device. Manufacturer: Implicity. The SignalHF System is intended for use by qualified healthcare professionals (HCP) managing patients over 18 years old who are receiving physiological monitoring for Heart Failure surveillance and implanted with a compatible Cardiac Implantable Electronic Devices (CIED) (i.e., compatible pacemakers, ICDs, and CRTs). The SignalHF System provides additive information to use in conjunction with standard clinical evaluation. The SignalHF HF Score is intended to calculate the risk of HF for a patient in the next 30 days. This System is intended for adjunctive use with other physiological vital signs and patient symptoms and information and is not intended to independently direct therapy.
See the instructions for use for more information.

Media Contact:
Sam Choinski
eMedia Junction
860-301-5058
samantha@emediajunction.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/implicitys-evidence-rm-study-demonstrates-marked-improvement-in-icd-patient-outcomes-302436176.html

SOURCE Implicity

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Mixx Technologies Acquires Sophic Silicon Technologies and Announces Manufacturing Collaboration with Kaynes Semicon

Published

on

By

A landmark dual announcement signals India’s emergence as a vertically integrated force in global AI semiconductor infrastructure, spanning design to deployment

BENGALURU, India, July 23, 2026 /PRNewswire/ — Mixx Technologies, Inc., a US based venture-backed deep-tech company building the interconnect layer for hyperscale AI infrastructure, today announced two simultaneous strategic moves that together mark a defining moment in India’s semiconductor journey. First, the acquisition of Sophic Silicon Technologies, a Bengaluru-based semiconductor IP design firm, beneficiary of India’s DLI and whose analog mixed-signal design expertise is now integral to Mixx’s co-packaged optics platform. Second, a manufacturing collaboration with Kaynes Semicon Private Limited, an Outsourced Semiconductor Assembly and Test (OSAT) specialist and beneficiary of India’s Production Linked Incentive (PLI) scheme, to establish a test and assembly facility that will support Mixx’s optical IC packaging roadmap. Taken together, the two announcements represent the first time an international deep-tech company has anchored both the design and manufacturing layers of a next-generation AI silicon platform in India, turning the country’s policy ambition into commercial reality.

The Acquisition: Completing the Full-Stack Foundation for Co-Packaged Optics
Every major cloud provider is deploying GPUs at a pace and scale that would have seemed implausible three years ago. But raw compute density is only half the equation. The harder problem is making sure those GPUs are working to its full potential and not waiting. In large AI clusters, accelerators spend a significant fraction of their time stalled on data waiting to move between chips fast enough to keep compute fed. The interconnect, not the GPU itself, is increasingly the binding constraint on utilization. And utilization directly determines the cost of a token and the energy burned to produce it. For hyperscalers running inference at billions of queries a day, the economics are unforgiving: every percentage point of GPU idle time is waste at scale. Introducing optics to declutter the data path improves efficiency. Co-packaged optics (CPO), the most effective solution to the interconnect bottleneck, integrates photonic engines directly alongside ASICs and accelerators, moving data at optical speeds and at a fraction of the power of conventional electrical interconnects. It unlocks the bandwidth density required to keep GPUs utilized efficiently and sustainably, bringing down both the cost of a token and the energy consumed to produce it.

The industry is focused, the demand is now, and Mixx is ready for real-world deployments.

Delivering CPO at hyperscale, however, requires precision across the full electronic-photonic stack; the hardest layer to design is the analog mixed-signal interface between the photonics and the digital system. That is precisely what Sophic Silicon Technologies has designed using advanced CMOS process nodes. Their IP now forms the electronic IC foundation of Mixx’s HBxIO™ platform – a multi-terabit, ultra-high-radix optical interconnect architecture purpose-built for large-scale AI inference and training. The acquisition brings Sophic Silicon’s full team and IP portfolio into Mixx, effective immediately.

“Our vision has always been to build the complete electronic-photonic stack. Sophic Silicon brings critical analog mixed-signal expertise that reinforces HBxIO and moves us closer to deploying optical connectivity at hyperscale.”

        — Vivek Raghuraman, CEO, Mixx Technologies

Sophic Silicon’s founders and core engineers, with backgrounds spanning advanced CMOS process design, EDA and IP development, and high-speed networking, will join Mixx’s core product development organization and continue expanding R&D operations in India.

“Sophic Silicon exists because optical connectivity at hyperscale demands more – lower power, higher bandwidth, seamless multi-protocol integration, and latency that lets networks perform at their absolute best. Mixx gives us the platform, the ecosystem, and the global reach to take that work where it was always meant to go. What we built in Bengaluru is now part of the infrastructure that the world’s largest computing deployments will run on.”

         — Deepak Pancholi, Founder, Sophic Silicon Technologies

The Collaboration: From Design to Deployment with Kaynes Semicon
Designing world-class semiconductor IP in India is a milestone. Manufacturing and testing it there is a transformation. Mixx Technologies’ collaboration with Kaynes Semicon Private Limited, a leading Indian OSAT provider and PLI beneficiary, is precisely that second step.

The collaboration brings together Kaynes Semicon’s advanced OSAT capabilities and Mixx’s optical IC design expertise to build a dedicated test and assembly capability for next-generation optical integrated circuits. Kaynes Semicon brings deep process knowledge in semiconductor assembly, packaging, and test, backed by the capital investment and institutional credibility of a PLI-supported program. For Mixx, the partnership creates a tightly integrated domestic manufacturing pathway for components of the HBxIO™ platform, enabling faster development cycles, closer collaboration between design and production teams, and the kind of end-to-end control that is essential when pushing the limits of optical IC performance.

“This multi-year collaboration with Mixx Technologies is a strong signal of where India’s semiconductor manufacturing ecosystem is headed. We have built the infrastructure and the process depth to support advanced optical IC packaging. Working with Mixx brings a world-class design partner into that ecosystem, demonstrating that PLI-backed Indian manufacturers can play at the leading edge of the global AI hardware supply chain.”

          — Raghu Panicker, CEO, Kaynes Semicon Private Limited

From India, for the World: A New Model for Semiconductor Globalization
Mixx Technologies has maintained R&D operations in India since its founding, alongside its San Jose headquarters and Taiwan facilities. The acquisition of Sophic Silicon deepens that presence significantly, embedding a team with leading-edge analog mixed-signal and photonics design experience into Mixx’s core product organization. The collaboration with Kaynes Semicon adds a manufacturing dimension: for the first time, a next-generation optical interconnect platform will have both its design and its assembly and test operations anchored in India. This is not an offshoring story. It is a story about India becoming a primary node in the global AI semiconductor value chain, with design, manufacturing, and IP origination happening here, at global scale.

“Mixx Technologies is committed to developing next-generation silicon photonics IP and system designs in India, contributing to the country’s ambition of becoming a global hub for semiconductor design and advanced manufacturing. The talent here is exceptional. The policy environment has matured to support it. And today’s announcements are what happens when both come together.”

           — Vivek Raghuraman, CEO, Mixx Technologies

The Road Ahead: Building the AI Interconnect Layer, in India
Sophic Silicon’s mixed-signal IPs is now being integrated across the HBxIO™ platform stack. Mixx is actively engaged with cloud service providers to qualify the platform across both scale-up and scale-out network, connecting servers and clusters across data center fabric.

The Kaynes Semicon collaboration is underway, focused on qualifying advanced optical IC assembly and test processes that meet the stringent performance and reliability standards hyperscale deployments demand. Mixx continues to expand its India R&D organization, with Bengaluru at the center of its global analog mixed-signal and photonics IC development.

The global AI chip market is projected to exceed $400 billion by 2030. The interconnect layer, tracking how data moves between chips, between accelerators and between clusters, is where the next wave of differentiation will be won. Mixx Technologies is building that layer. And it is building it in India.

About Mixx Technologies
Mixx Technologies, Inc. is venture-backed deep-tech company founded by the team that commercialized many zero-to-one silicon photonics products. The company is solving the data-movement bottleneck for AI compute infrastructure through its HBxIO™ platform, a multi-terabit, ultra-high-radix co-packaged optical interconnect architecture enabling cloud service providers to deploy large-scale AI inference at the speed and efficiency hyperscale demands. Headquartered in San Jose, California, with R&D operations in India and Taiwan. Visit: www.mixxtech.io.

About Sophic Silicon Technologies
Sophic Silicon Technologies is a Bengaluru-based semiconductor IP design firm specializing in analog mixed-signal, wireless and photonics ICs for AI-scale infrastructure. A beneficiary of India’s Design Linked Incentive (DLI) Scheme under the India Semiconductor Mission, the company developed its IP at leading-edge CMOS process nodes to address the electro-optic interface challenges central to co-packaged optics and next-generation AI scale-up interconnects. Sophic Silicon Technologies is now part of Mixx Technologies.

About Kaynes Semicon Private Limited
Kaynes Semicon Private Limited is an Indian OSAT (Outsourced Semiconductor Assembly and Test) company and beneficiary of the Government of India’s Production Linked Incentive (PLI) scheme for semiconductors. With infrastructure and advanced assembly capabilities at its Sanand, Gujarat facility, Kaynes Semicon is building India’s domestic semiconductor manufacturing ecosystem for next-generation packaging and test requirements.

Media Contact
Ramya Barna
Marketing and Investor Relations, Mixx Technologies, Inc
info@mixxtech.io

Photo – https://mma.prnewswire.com/media/3007336/Mixx_Technologies_System_Level_Solution.jpg
Logo – https://mma.prnewswire.com/media/2834697/Mixxblack_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/mixx-technologies-acquires-sophic-silicon-technologies-and-announces-manufacturing-collaboration-with-kaynes-semicon-302832530.html

Continue Reading

Technology

Hydra X Launches HX Gateway API to Advance Institutional Adoption on the Canton Network

Published

on

By

The HX Gateway API supports financial institutions and developers building on Canton, reducing go-to-market timelines by up to 80% and deployment time by 50%.

SINGAPORE, July 23, 2026 /PRNewswire/ — Hydra X, a regulated market infrastructure operator for tokenised capital markets, today announced the launch of HX Gateway API, a REST API layer that supports financial institutions and application developers building on the Canton Network without requiring specialised expertise in Daml, Canton’s underlying programming language.

The API provides a straightforward integration layer that maps directly to familiar business workflows – onboarding participants, issuing and managing assets, and executing transfers. Now, institutions can go from decision to deployment without needing to build infrastructure from the ground up.

Built on Production Experience on the Canton Network

The HX Gateway API is built on Hydra X’s own production experience operating on the Canton Network. The firm has tokenised over US$100 million in assets for institutional clients across multiple regulatory frameworks on Canton through DA Registry – a secure tokenisation solution with regulatory-grade compliance built by Digital Asset, creators of the Canton Network.

That operational depth informed the design of the API, resulting in measurable gains for institutional deployments:

Rapid Go-to-Market: Up to an 80% acceleration in go-to-market timelines.Faster Path-to-Production: A 50% reduction in deployment time.Flexible Integration: Available as a hosted service or as an external deployment for clients with existing validator infrastructure.

“The HX Gateway API was designed to advance institutional adoption on the Canton Network.  It is built on the same infrastructure we run in production for regulated clients, and it means that banks, asset managers and exchanges no longer need to treat Canton integration as a specialist engineering project. It is a business decision now, and the timelines reflect that,” said Mark Tang, VP of Client Solutions, Hydra X.

A Broader Shift in Tokenised Capital Markets

The launch marks a broader shift in how regulated financial institutions can engage with the Canton Network. As tokenised capital markets around the world move from pilot programmes to production deployments, the ability to integrate quickly and reliably into shared network infrastructure is becoming a competitive differentiator. The HX Gateway API is designed to meet that moment, providing institutional-grade tooling that significantly accelerates the path from deciding to build on the Canton Network to achieving a live deployment.

About Hydra X

Hydra X is a regulated market infrastructure operator for tokenised capital markets, with live deployments across Asia-Pacific. The firm builds and operates the full lifecycle of digital capital market infrastructure, spanning tokenisation, distribution, trading, custody and settlement. Hydra X serves financial institutions seeking to issue, trade and custodise digital assets on regulated, institutional-grade infrastructure.

www.hydrax.io

View original content:https://www.prnewswire.com/apac/news-releases/hydra-x-launches-hx-gateway-api-to-advance-institutional-adoption-on-the-canton-network-302832706.html

SOURCE Hydra X

Continue Reading

Technology

Unfold Your Passions with a $0 Galaxy on StarHub 5G Unlimited+ Plans

Published

on

By

Pre-order the new Samsung Galaxy Z Fold8 Ultra, Galaxy Z Fold8 and Galaxy Z Flip8 with StarHub to unlock exclusive perks

SINGAPORE, 23 July 2026 /PRNewswire/ — Your next Galaxy upgrade just got easier. Whether it’s streaming Premier League action on the go, multi-tasking on a larger foldable display or enjoying immersive entertainment, StarHub is making it easier than ever to own Samsung’s latest Galaxy foldables.

From today, customers can pre-order the new Samsung Galaxy Z Fold8 Ultra, Galaxy Z Fold8, and Galaxy Z Flip8 on StarHub’s 5G Unlimited+ Plans, enjoying up to $1,688 in device savings, up to $2,880 in DeviceDollars (over 36 months) to offset interest-free device instalments, bringing the cost of owning Samsung’s latest foldables down to as low as $0.

More Value with Every Upgrade

Designed to make upgrading easier and more rewarding, StarHub’s 5G Unlimited+ Plans combine exclusive pre-order offers with perks, so customers get even more from Samsung’s latest Galaxy foldables:

Up to $2,880 in DeviceDollars (over 36 months) to offset interest-free instalments, with flexible payment options across 12, 24 or 36 monthsUpfront pay later device discounts with 5G Unlimited+ PlansUp to $350 off device for new lines and port-insGuaranteed $300 trade-in bonus on top of device’s base trade-in valueComplimentary Premier League Annual Pass worth $380 with Galaxy Z Fold8 Ultra or Fold8Complimentary storage upgrade to 512GB at the price of 256GB worth $300, with 5G Unlimited+ Plus Plans and aboveComplimentary 3 months SmartSupport (worth $42.78) to lock in the 50% trade-in guarantee on your new Galaxy Z Foldable[1]$38 e-voucher for customers who registered their interestWatch add-on savings of up $250 off Galaxy Watch Ultra2 and $100 off Galaxy Watch9

More Freedom with 5G Unlimited+ Plans

Beyond the device, StarHub’s 5G Unlimited+ Plans include unlimited data, built-in global roaming across 165 destinations, and unlimited calls and SMS, giving customers greater peace of mind whether they’re staying connected at home or travelling overseas.

Pre-Order Details

Customers can pre-order the new Samsung Galaxy Z Series, Galaxy Watch Ultra2 and Galaxy Watch9 on StarHub’s 5G Unlimited+ Plans from 23 July 2026, 9am to 13 August 2026, 11.59pm via the StarHub App and online at starhub.com/samsung. Customers who prefer to pre-order in person can do so at StarHub Shops from 4 August 2026, during operating hours.

The Samsung Galaxy Z Series will be available for walk-in purchase at StarHub shops from 14 August 2026, 11am, and online via the StarHub eShop from 14 August 2026, 12am, while stocks last.

For more information, visit: starhub.com/samsung.

[1] Terms and conditions apply, please refer to starhub.com/samsung

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/unfold-your-passions-with-a-0-galaxy-on-starhub-5g-unlimited-plans-302832777.html

SOURCE StarHub

Continue Reading

Trending